NM_000601.6:c.910G>A

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000601.6(HGF):​c.910G>A​(p.Glu304Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0567 in 1,613,660 control chromosomes in the GnomAD database, including 3,071 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.043 ( 195 hom., cov: 32)
Exomes 𝑓: 0.058 ( 2876 hom. )

Consequence

HGF
NM_000601.6 missense

Scores

5
13

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 1.83
Variant links:
Genes affected
HGF (HGNC:4893): (hepatocyte growth factor) This gene encodes a protein that binds to the hepatocyte growth factor receptor to regulate cell growth, cell motility and morphogenesis in numerous cell and tissue types. Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed to generate alpha and beta chains, which form the mature heterodimer. This protein is secreted by mesenchymal cells and acts as a multi-functional cytokine on cells of mainly epithelial origin. This protein also plays a role in angiogenesis, tumorogenesis, and tissue regeneration. Although the encoded protein is a member of the peptidase S1 family of serine proteases, it lacks peptidase activity. Mutations in this gene are associated with nonsyndromic hearing loss. [provided by RefSeq, Nov 2015]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0023468137).
BP6
Variant 7-81729735-C-T is Benign according to our data. Variant chr7-81729735-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 43611.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-81729735-C-T is described in Lovd as [Benign]. Variant chr7-81729735-C-T is described in Lovd as [Likely_benign].
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0629 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
HGFNM_000601.6 linkc.910G>A p.Glu304Lys missense_variant Exon 8 of 18 ENST00000222390.11 NP_000592.3 P14210-1
HGFNM_001010932.3 linkc.895G>A p.Glu299Lys missense_variant Exon 8 of 18 NP_001010932.1 P14210-3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
HGFENST00000222390.11 linkc.910G>A p.Glu304Lys missense_variant Exon 8 of 18 1 NM_000601.6 ENSP00000222390.5 P14210-1
HGFENST00000457544.7 linkc.895G>A p.Glu299Lys missense_variant Exon 8 of 18 1 ENSP00000391238.2 P14210-3

Frequencies

GnomAD3 genomes
AF:
0.0426
AC:
6474
AN:
151966
Hom.:
196
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0108
Gnomad AMI
AF:
0.0626
Gnomad AMR
AF:
0.0389
Gnomad ASJ
AF:
0.128
Gnomad EAS
AF:
0.000582
Gnomad SAS
AF:
0.0108
Gnomad FIN
AF:
0.0326
Gnomad MID
AF:
0.146
Gnomad NFE
AF:
0.0645
Gnomad OTH
AF:
0.0493
GnomAD3 exomes
AF:
0.0457
AC:
11485
AN:
251390
Hom.:
393
AF XY:
0.0467
AC XY:
6339
AN XY:
135868
show subpopulations
Gnomad AFR exome
AF:
0.00849
Gnomad AMR exome
AF:
0.0284
Gnomad ASJ exome
AF:
0.132
Gnomad EAS exome
AF:
0.000109
Gnomad SAS exome
AF:
0.0117
Gnomad FIN exome
AF:
0.0375
Gnomad NFE exome
AF:
0.0662
Gnomad OTH exome
AF:
0.0556
GnomAD4 exome
AF:
0.0581
AC:
84949
AN:
1461576
Hom.:
2876
Cov.:
32
AF XY:
0.0573
AC XY:
41660
AN XY:
727112
show subpopulations
Gnomad4 AFR exome
AF:
0.00863
Gnomad4 AMR exome
AF:
0.0290
Gnomad4 ASJ exome
AF:
0.136
Gnomad4 EAS exome
AF:
0.0000756
Gnomad4 SAS exome
AF:
0.0122
Gnomad4 FIN exome
AF:
0.0389
Gnomad4 NFE exome
AF:
0.0653
Gnomad4 OTH exome
AF:
0.0590
GnomAD4 genome
AF:
0.0425
AC:
6467
AN:
152084
Hom.:
195
Cov.:
32
AF XY:
0.0398
AC XY:
2957
AN XY:
74338
show subpopulations
Gnomad4 AFR
AF:
0.0108
Gnomad4 AMR
AF:
0.0387
Gnomad4 ASJ
AF:
0.128
Gnomad4 EAS
AF:
0.000583
Gnomad4 SAS
AF:
0.0108
Gnomad4 FIN
AF:
0.0326
Gnomad4 NFE
AF:
0.0645
Gnomad4 OTH
AF:
0.0488
Alfa
AF:
0.0627
Hom.:
853
Bravo
AF:
0.0427
TwinsUK
AF:
0.0609
AC:
226
ALSPAC
AF:
0.0703
AC:
271
ESP6500AA
AF:
0.0113
AC:
50
ESP6500EA
AF:
0.0702
AC:
604
ExAC
AF:
0.0447
AC:
5433
Asia WGS
AF:
0.00751
AC:
26
AN:
3478
EpiCase
AF:
0.0676
EpiControl
AF:
0.0711

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
Aug 16, 2016
Eurofins Ntd Llc (ga)
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

May 07, 2012
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

Glu304Lys in Exon 08 of HGF: This variant is not expected to have clinical signi ficance because it has been identified in 7.3% (510/7020) of European American c hromosomes from a broad population by the NHLBI Exome Sequencing Project (http:/ /evs.gs.washington.edu/EVS; dbSNP rs5745687). -

Oct 05, 2017
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
PreventionGenetics, part of Exact Sciences
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

not provided Benign:2
Jan 29, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

Nonsyndromic Hearing Loss, Mixed Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.071
BayesDel_addAF
Benign
-0.49
T
BayesDel_noAF
Benign
-0.42
CADD
Benign
21
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.51
D;D;.
Eigen
Benign
-0.0015
Eigen_PC
Benign
0.11
FATHMM_MKL
Uncertain
0.76
D
LIST_S2
Uncertain
0.91
.;D;D
MetaRNN
Benign
0.0023
T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Uncertain
2.3
M;M;.
PrimateAI
Benign
0.38
T
PROVEAN
Benign
-1.2
.;N;N
REVEL
Benign
0.086
Sift
Benign
0.47
.;T;T
Sift4G
Benign
0.66
.;T;T
Polyphen
0.38
B;B;P
Vest4
0.10, 0.15
MPC
0.67
ClinPred
0.014
T
GERP RS
4.5
Varity_R
0.29
gMVP
0.81

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs5745687; hg19: chr7-81359051; COSMIC: COSV55947966; API